New Zealand markets open in 6 hours 25 minutes

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
58.09+0.24 (+0.41%)
As of 09:35AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 167.83B
Enterprise value 192.60B
Trailing P/E 97.33
Forward P/E 16.50
PEG ratio (5-yr expected) 0.97
Price/sales (ttm)4.49
Price/book (mrq)4.21
Enterprise value/revenue 5.87
Enterprise value/EBITDA 24.31

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 311.04%
S&P500 52-week change 316.15%
52-week high 364.21
52-week low 346.48
50-day moving average 357.05
200-day moving average 357.66

Share statistics

Avg vol (3-month) 34.86M
Avg vol (10-day) 35.46M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 82.98B
% held by insiders 10.05%
% held by institutions 117.44%
Shares short (30 Dec 2021) 46.18M
Short ratio (30 Dec 2021) 41.39
Short % of float (30 Dec 2021) 4N/A
Short % of shares outstanding (30 Dec 2021) 40.20%
Shares short (prior month 29 Nov 2021) 47.55M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 42.46%
Trailing annual dividend rate 33.70
Trailing annual dividend yield 36.40%
5-year average dividend yield 43.35
Payout ratio 4252.25%
Dividend date 312 Sep 2021
Ex-dividend date 411 Aug 2021
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 4.48%
Operating margin (ttm)9.80%

Management effectiveness

Return on assets (ttm)2.35%
Return on equity (ttm)5.48%

Income statement

Revenue (ttm)32.82B
Revenue per share (ttm)12.08
Quarterly revenue growth (yoy)50.00%
Gross profit (ttm)21.37B
Net income avi to common (ttm)1.47B
Diluted EPS (ttm)0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.15B
Total cash per share (mrq)2.39
Total debt (mrq)34.39B
Total debt/equity (mrq)86.16
Current ratio (mrq)1.13
Book value per share (mrq)13.28

Cash flow statement

Operating cash flow (ttm)6.34B
Levered free cash flow (ttm)-1.39B